Olema Pharmaceuticals (OLMA) vs Pharming Group N.V. (PHAR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Olema Pharmaceuticals (OLMA) has outperformed Pharming Group N.V. (PHAR) over the past year, losing 23.9% versus a loss of 34.2%. Over five years, PHAR leads with a +2.2% price change compared with -74.1% for OLMA. Olema Pharmaceuticals is the larger company by market cap ($694.7 million vs $683.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OLMA | PHAR |
|---|---|---|
| Share price | $7.94 | $9.65 |
| Market cap | $694.73M | $683.01M |
| 1-day change | +0.25% | -0.31% |
| YTD return | -68.24% | -45.39% |
| 1-year return | -23.95% | -34.22% |
| 5-year return | -74.15% | +2.22% |
| P/E ratio (TTM) | — | 74.23 |
| Forward P/E | — | 31.43 |
| EPS (TTM) | $-2.12 | $0.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $36.26 | $21.34 |
| 52-week low | $6.65 | $9.59 |
| Distance from 52-week high | -78.10% | -54.78% |
| Average volume | 1.07M | 22.88K |
| Shares outstanding | 87.50M | 70.78M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OLMA has outperformed PHAR by 10.3 percentage points over the past year.
OLMA vs PHAR FAQ
Which is bigger, Olema Pharmaceuticals or Pharming Group N.V.?
Olema Pharmaceuticals (OLMA) is larger, with a market capitalization of $694.73M compared with $683.01M for Pharming Group N.V. (PHAR).
Which stock has performed better over the past year, OLMA or PHAR?
OLMA returned -23.95% over the past 12 months, compared with -34.22% for PHAR (price return, excluding dividends). Past performance does not predict future results.
Are Olema Pharmaceuticals and Pharming Group N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.